期刊
DALTON TRANSACTIONS
卷 45, 期 45, 页码 18333-18345出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c6dt03502g
关键词
-
资金
- Department of Chemistry, Isfahan University of Technology (IUT)
Three new ruthenium(II) complexes of NCN pincer and phenylcyanamide derivative ligands of the formula [Ru(L)(Ph(2)phen)(3,5-(NO2)(2)pcyd)], 1, [Ru(L)(Me(2)phen)(3,5-(NO2)(2)pcyd)], 2, and [Ru(L)(Cl(2)phen)(3,5-( NO2)(2)pcyd)], 3 (HL: 5-methoxy-1,3-bis(1-methyl-1H-benzo[d] imidazol-2-yl) benzene, 3,5-(NO2)(2)pcyd: 3,5-(NO2)(2)pcyd, Ph2phen: 4,7-diphenyl-1,10-phenanthroline, Me(2)phen: 4,7-dimethyl-1,10-phenanthroline, Cl(2)phen: 4,7-dichloro-1,10-phenanthroline) have been synthesized and studied as potential photosensitizers (PSs) in photodynamic therapy (PDT). The complexes exhibited promising O-1(2) production quantum yields comparable with PSs available on the market. The DNA-binding interactions of the complexes with calf thymus DNA have been studied by absorption, emission, and viscosity measurements. All complexes cleave SC-DNA efficiently on photoactivation at 350 nm with the formation of singlet oxygen (O-1(2)) and hydroxyl radicals ((OH)-O-center dot) in type-II and photoredox pathways. Complexes 1-3 showed very good uptake in cervical cancer cells (HeLa). The compounds studied were found to exhibit low toxicity against HeLa cells (IC50 > 300 mu M) and, remarkably, on non-cancerous MRC-5 cells (IC50 > 100 mu M) in the dark. However, 1 showed very promising behavior with an increment of about 90 times, in its cytotoxicity upon light illumination at 420 nm in addition to very good human plasma stability.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据